it s remarkable how little we still fully understand. but i think we can we can probably safely say, it s going to change dramatically. i think the majority of the questions, interestingly enough, really focused on federal entitlements like medicare and medicaid. there were fewer questions about the exchanges of the affordable care act specifically, and even fewer questions about the stock concerns of congressman price. with regards to medicare and medicaid, you know, the idea that he s brought forth and he s been releasing his own plans over the last seven years now, congressman price has, basically saying he wants to create a premium support sort of program. meaning that, yeah, you can still buy medicare. we ll give you the amount of money medicare costs now. you can buy medicare if you want it or use that money to buy private insurance. the big concern brought up by a few senators, that money won t may be enough now, but it won t be enough next year or the year after that. ultim
packing hurricane speed winds. the same weather system responsible for at least 20 people confirmed dead, most of them net state of georgia. it s migrate privilege to welcome mike pompeo as the new director of the central intelligence agency. biggest objection the democrats have to republican nominees is they are republican. , period. brian: that s the capitol building. we were just there about 36 hours ago. that s where so much of the action is taking place. legislation going to be flying. the senate is empowered. they are supposed to be confirming a lot of people or at least analyzing a lot of the people that donald trump put forward. how is it going? ainsley: pompeo was the latest. tillerson looks like is he going to be next. congressman price they are still evaluating. ainsley: chuck schumer is taking his time delaying it.
saying, tell us what you believe in, and we know that congressman price has wanted to take a whack at medicare, at medicaid, at patient care, and making sure that working people have the care they need in the united states and around the world is part of what we stand for and i think that s what senator mccaskill was pointing out. i think andrea we ve got a big problem. even though we re going through the cabinet nominations at the state department, at the defense department, all of the undersecretaries, the deputy secretaries, the assistant secretaries are not filled out. so the president being able to move on really key national security issues, including prime minister may coming here tomorrow from great britain is really quite tough. a quick question. what are you hearing about the staffing of the national security council, where there are people deployed from other agencies and it has become bloated and criticized in the past, are there any directors in place sh? these are not c
and i would invite you, congressman, to please respond with the cbo report yesterday that you says supports your position, because this one does not. look forward to that. senator menendez? thank you, chairman. congratulations, congressman price. let me ask you a series of questions. given your medical training and time spent as a practicing physician, i have a couple of simple yes or no questions to start off with. in your medical opinion, does hiv cause aids? i think that the scientific evidence is clear that hiv and aids are clinically directed or. in your medical opinion, have immigrants led to outbreaks of leprosy in the united states? i don t know what you re referring to, but i suspect that there are instances where individuals have an infectious disease and they come to the united states i m not asking about an infectious disease, i m asking specifically about immigrants in
congressman price s own record undercuts these promises. i m going to start with ethics and undisclosed assets. congressman price owns stock in an australian biomedic they were called immuneo therapeutics. his first stock purchase came in 2015, after consulting representative chris collins, the company s top shareholder and a member of its board. in 2016, the congressman was invited to participate in a special stock sale called a private placement. the company offered the private placement to raise funds for testing on an experimental treatment it intends to put up for fda approval. through this private placement, the congressman increased his stake in the company by more than 500%. he has said he was unaware he paid a price below market value.